2023
Methamphetamine-Associated Catatonia: Case Series and Systematic Review of the Literature from 1943-2020
Slavnic B, Barnett B, McIntire S, Becker R, Saba S, Vellanki K, Honaker L, Weleff J, Carroll B. Methamphetamine-Associated Catatonia: Case Series and Systematic Review of the Literature from 1943-2020. Annals Of Clinical Psychiatry 2023, 35: 167-177. PMID: 37459499, DOI: 10.12788/acp.0116.Peer-Reviewed Original ResearchConceptsAssociated with catatoniaCatatonia Rating ScaleMethamphetamine useGeneral medical conditionsCase seriesBush-Francis Catatonia Rating ScaleSystematic reviewUrine drug screensMedical conditionsRating ScaleCases of catatoniaDSM-5 criteriaShorter hospitalDopamine functionCatatonic patientsCatatoniaDSM-5MethamphetaminePatientsNeural mechanismsSubstance intoxicationDrug screeningHospitalReviewLorazepam
2022
Catatonia After COVID-19
Nikayin S, Chaffkin J, Ostroff RB. Catatonia After COVID-19. Journal Of Ect 2022, 38: e43-e44. PMID: 35220361, PMCID: PMC9426344, DOI: 10.1097/yct.0000000000000838.Peer-Reviewed Original Research
2021
Prevalent Gaps in Understanding the Features of Catatonia Among Psychiatrists, Psychiatry Trainees, and Medical Students.
Wortzel J, Maeng D, Francis A, Oldham M. Prevalent Gaps in Understanding the Features of Catatonia Among Psychiatrists, Psychiatry Trainees, and Medical Students. The Journal Of Clinical Psychiatry 2021, 82 PMID: 34406716, DOI: 10.4088/jcp.21m14025.Peer-Reviewed Original ResearchConceptsBush-Francis Catatonia Rating ScalePsychiatry traineesCatatonic featuresCatatonia Rating ScaleMedical studentsConsultation-liaison psychiatristsFeatures of catatoniaAcademy of Consultation-Liaison PsychiatryConsultation-liaison psychiatryMultiple-choice testRating ScaleCatatoniaOlder participantsPsychiatristsPsychiatryPsychiatry residentsYounger participantsStages of trainingEmail invitationPatient careYears of experiencePsychiatry clerkshipHeterogeneous phenotypesResidency directorsPrevalence gapEmergent and Non-Emergent Agitation in the Older Adult: Evaluation and Management
Subramanian S, Fahed M, Dix E, Wilkins K. Emergent and Non-Emergent Agitation in the Older Adult: Evaluation and Management. Current Geriatrics Reports 2021, 10: 73-81. DOI: 10.1007/s13670-021-00358-6.Peer-Reviewed Original ResearchCohen-Mansfield Agitation InventoryElectroconvulsive therapyOlder adultsPsychiatric disordersNon-pharmacological managementAlcohol withdrawalDistressing symptomsBenzodiazepine usePharmacological treatmentTreatment optionsExcited catatoniaHeterogenous presentationSuccessful treatmentSignificant disabilitySubstance intoxicationNeuropsychiatric conditionsMotor behaviorCognitive enhancersPolypharmacyAdultsDeliriumPatientsCatatoniaReviewThis paperTreatment
2019
Clinical factors contributing to morbidity, mortality, and cost in patients requiring ECT for the management of catatonia
Kitay B, Ostroff R. Clinical factors contributing to morbidity, mortality, and cost in patients requiring ECT for the management of catatonia. Brain Stimulation 2019, 12: 462. DOI: 10.1016/j.brs.2018.12.503.Peer-Reviewed Original Research
2018
Immunotherapy in selected patients with Down syndrome disintegrative disorder
Cardinale KM, Bocharnikov A, Hart SJ, Baker JA, Eckstein C, Jasien JM, Gallentine W, Worley G, Kishnani PS, Van Mater H. Immunotherapy in selected patients with Down syndrome disintegrative disorder. Developmental Medicine & Child Neurology 2018, 61: 847-851. PMID: 30548468, DOI: 10.1111/dmcn.14127.Peer-Reviewed Original ResearchConceptsCognitive declineDisintegrative disorderDown syndromeHistory of autoimmunitySmall case seriesAutoimmune thyroid diseaseSymptoms of catatoniaAdditional immunotherapyIntravenous immunoglobulinCase seriesMedical recordsThyroid diseaseImmunotherapyPAPER ADDSPatientsCatatoniaInsomniaCore symptomsPsychosisAutistic featuresYoung adultsSymptomsAutoimmunityDisordersSyndrome
2014
Adolescent Catatonia Successfully Treated with Lorazepam and Aripiprazole
Roberto AJ, Pinnaka S, Mohan A, Yoon H, Lapidus KA. Adolescent Catatonia Successfully Treated with Lorazepam and Aripiprazole. Case Reports In Psychiatry 2014, 2014: 309517. PMID: 25184067, PMCID: PMC4145739, DOI: 10.1155/2014/309517.Peer-Reviewed Original ResearchSuccessful treatment modalityEmotional distressAdolescent catatoniaNeuroleptic medicationTreatment modalitiesCase reportCatatonia syndromePsychotic symptomsPrevious historyDifficulty communicatingCatatoniaSignificant impairmentPatientsSymptomsPsychotic thoughtChildrenDistressAdolescentsMedicationsUnderdiagnosisAripiprazoleSyndromeLorazepam
2013
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse
Leibu E, Garakani A, McGonigle DP, Liebman LS, Loh D, Bryson EO, Kellner CH. Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse. Journal Of Ect 2013, 29: e61-e62. PMID: 23670023, DOI: 10.1097/yct.0b013e318290fa36.Peer-Reviewed Case Reports and Technical Notes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply